Table 3.
Mouse sera (%) | Human sera (%) | |
---|---|---|
C3a levels | ||
No mAb to factor B with: | ||
Ca++ sufficient buffer (both CP and AP) | 100 | 100 |
Ca++ deficient buffer (AP only) | 76.6 ± 3.6* | 88.9 ± 4.5* |
(range) | (33–106) | (45–140) |
mAb to factor B with: | ||
Ca++ sufficient buffer (CP only) | 60.5 ± 3.3** | 71.0 ± 2.8** |
(range) | (33–91) | (43–102) |
Ca++ deficient buffer (no CP or AP) | 0 | 5.3 ± 1.1 |
C5a levels | ||
No mAb to factor B with: | ||
Ca++ sufficient buffer (both CP and AP) | 100 | 100 |
Ca++ deficient buffer (AP only) | 79.1 ± 3.6*** | 62.8 ± 3.8*** |
(range) | (14–116) | (18–110) |
mAb to factor B with: | ||
Ca++ sufficient buffer (CP only) | 46.6 ± 2.8**** | 74.3 ± 2.2**** |
(range) | (4–92) | (48–94) |
Ca++ deficient buffer (no CP or AP) | 0 | 0.8 ± 0.6 |
P-values for mouse versus human sera:
P = 0·04;
P = 0·02;
P = 0·003;
P < 0·0001.
The data for up to six experiments were normalized to 100% of the values obtained in the absence of monoclonal antibody (mAb) to factor using Ca++ sufficient buffer.
The data are expressed as mean ± standard error of the mean based on n = 34 human sera for both assays, n = 45 murine sera for C5a levels and n = 24 murine sera for C3a levels. AP, alternative pathway; CO, classical pathway.